Breaking News
Get 40% Off 0
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks. Unlock full list
Close

Haba Laboratories Inc (4925)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2,080.0 -4.0    -0.19%
08:00:00 - Delayed Data. Currency in JPY ( Disclaimer )
Type:  Equity
Market:  Japan
ISIN:  JP3765130004 
  • Volume: 200
  • Bid/Ask: 2,076.0 / 2,085.0
  • Day's Range: 2,080.0 - 2,080.0
Haba Laboratories 2,080.0 -4.0 -0.19%

4925 Balance Sheet

 
Featured here, the Balance Sheet for Haba Laboratories Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
Advanced Balance Sheet
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Total Current Assets 9076 9155 9052 8643
Cash and Short Term Investments 3959 3771 3636 3757
Cash - - - -
Cash & Equivalents 3959 3771 3636 3757
Short Term Investments - - - -
Total Receivables, Net 1259 1060 1063 930
Accounts Receivables - Trade, Net 1259 1060 1063 930
Total Inventory 3713 4074 4082 3628
Prepaid Expenses - - - -
Other Current Assets, Total 145 250 271 328
Total Assets 12431 14204 14408 13979
Property/Plant/Equipment, Total - Net 2955 4241 4302 4357
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net - - - -
Intangibles, Net - 408 340 335
Long Term Investments 315 307 309 309
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 2 2 2 1
Other Assets, Total 2682 3355 3693 3360
Total Current Liabilities 2813 3252 3025 2674
Accounts Payable 303 272 657 369
Payable/Accrued - - - -
Accrued Expenses - - - -
Notes Payable/Short Term Debt 600 600 200 200
Current Port. of LT Debt/Capital Leases 754 845 866 780
Other Current liabilities, Total 1156 1535 1302 1325
Total Liabilities 3925 4493 4130 3572
Total Long Term Debt 1000 1141 1052 845
Long Term Debt 1000 1141 1052 845
Capital Lease Obligations - - - -
Deferred Income Tax 50 46 - -
Minority Interest - - - -
Other Liabilities, Total -538 -546 -2266.1 -1972.88
Total Equity 8506 9711 10278 10407
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 696 696 696 696
Additional Paid-In Capital 812 812 812 812
Retained Earnings (Accumulated Deficit) 8128 9335 9902 10032
Treasury Stock - Common -1135 -1135 -1135 -1135
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 5 3 3 2
Total Liabilities & Shareholders' Equity 12431 14204 14408 13979
Total Common Shares Outstanding 3.78 3.78 3.78 3.78
Total Preferred Shares Outstanding - - - -
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

4925 Comments

Write your thoughts about Haba Laboratories Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email